Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App





Anatolia Geneworks Unveils High-Throughput Molecular Diagnostics Platform at MEDICA 2025

By LabMedica International staff writers
Posted on 18 Nov 2025

Anatolia Geneworks is exhibiting at MEDICA 2025, where the company is showcasing its portfolio of products, including nucleic acid extraction kits, rapid diagnostic kits, Real-Time PCR kits, automated extraction devices, and PCR setup robots. More...

At MEDICA 2025, Anatolia is introducing a new fully automated “sample-to-result” system designed to streamline real-time PCR workflows. UNIO 448 is a fully automated molecular diagnostics system that integrates Bosphore Real‑Time PCR kits into a seamless, end‑to‑end workflow. The platform is designed to deliver full automation, high throughput, and reliable performance across a broad diagnostic portfolio, consolidating specimen processing and amplification to support efficient routine testing.

Visitors can meet the Anatolia team in Hall 1, Booth B31 to review the system’s automated workflow and how Bosphore assays are integrated for molecular detection. Positioning UNIO 448 as an efficiency‑oriented platform, the company highlights the combination of automation and throughput intended to support laboratories managing diverse testing menus.

Related Links:
Anatolia Geneworks


Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Urine Chemistry Control
Dropper Urine Chemistry Control
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The TmS computational biomarker analyzes tumor gene expression and microenvironment data to guide treatment decisions (Photo courtesy of MD Anderson Cancer Center)

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more

Industry

view channel
Image: The initiative aims to speed next-generation diagnostic development during early pathogen emergence (photo courtesy of 123RF)

Cepheid Joins CDC Initiative to Strengthen U.S. Pandemic Testing Preparednesss

Cepheid (Sunnyvale, CA, USA) has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators in a federal initiative to speed rapid diagnostic technologies... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.